Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 13,225 shares at $3.86 ($51K) on 2017-10-13, disclosed to the SEC on 2017-10-17.
Open-market sale of $51k FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.86 | 12,525 | $48K | 94.4% |
| 2 | $4.08 | 700 | $3K | 5.6% |
| Total | $3.87 avg | 13,225 | $51K | 100% |
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |